Why One Hormone Panel Rarely Settles the Question
A single hormone snapshot misses the natural variability of the transition.
- Clinical: Diagnosis basis (symptoms plus history first)
- High: FSH cycle swing (varies month to month)
- Limited role: Guideline stance (routine testing discouraged)
- Atypical cases: Best use case (age under 45)
One draw, one moment in time
A single sample cannot represent a fluctuating hormonal pattern.
Reference ranges overlap with normal cycling
Perimenopausal and reproductive-age values often look similar on paper.
FSH Swings Make Single Readings Misleading
FSH can be elevated one cycle and normal the next.
- Wide: Cycle-to-cycle swing (especially early transition)
- ~25-40: Menopausal cutoff (mIU/mL, lab dependent)
- Often: Repeat testing need (single value insufficient)
- High: Timing sensitivity (cycle day matters)
Follicular recruitment varies month to month
Recruiting follicles change output, so FSH bounces unpredictably.
A normal FSH does not exclude perimenopause
A low reading in one cycle can be high in the next.
AMH Offers a Steadier Ovarian Reserve Signal
AMH declines gradually and fluctuates far less across the cycle.
- High: Cycle stability (minimal day-to-day change)
- Reserve: Reflects (not menopause timing directly)
- Gradual: Typical decline (over years, not days)
- Moderate: Predictive limit (poor for timing final period)
AMH tracks remaining follicle pool
Lower AMH suggests fewer remaining follicles, not exact menopause timing.
Useful but not a standalone diagnosis
AMH supports the picture but does not confirm perimenopause alone.
Symptoms and History Usually Decide the Diagnosis
Menstrual pattern changes and symptoms typically outweigh lab numbers.
- Cycle pattern: Primary criteria (irregularity, spacing changes)
- 45-55: Typical age range (testing rarely needed here)
- High: Symptom weight (hot flashes, sleep, mood)
- Low: Lab weight (in typical-age presentations)
STRAW staging relies on cycle history
Staging frameworks lean on bleeding patterns over hormone values.
Guidelines discourage routine hormone testing
Major societies favor clinical criteria for typical-age patients.
When Hormone Labs Genuinely Help
Testing adds value for early onset, atypical, or ambiguous cases.
- Age <45: High-value case (early or premature concern)
- Fertility planning: Also useful (AMH for reserve estimate)
- Ruling out: Also useful (thyroid, pregnancy, other causes)
- Typical age: Low-value case (classic symptom pattern)
Early or premature ovarian insufficiency workup
Younger patients with symptoms benefit most from targeted testing.
Excluding other conditions with overlapping symptoms
Labs help exclude thyroid disease, pregnancy, or other causes.